Community Healthcare Trust (CHCT) opened Q1 2026 with total revenue of US$31.5 million, basic EPS of US$0.07, and net income of US$1.8 million, while FFO reached US$13.4 million, putting the focus firmly on cash generation from its healthcare properties. Over recent quarters the company has seen revenue move from US$29.3 million in Q4 2024 to between about US$30.1 million and US$31.5 million across 2025 and into Q1 2026. EPS has ranged from a loss of US$0.50 to a profit of US$0.51. For investors, the key question now is how stable these margins and cash flows look as one off items fade and the latest results reset expectations.
See our full analysis for Community Healthcare Trust.With the headline numbers on the table, the next step is to see how they stack up against the dominant stories around Community Healthcare Trust and where those narratives may need updating.
See what the community is saying about Community Healthcare Trust
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Community Healthcare Trust on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
Mixed messages on income, dividends and valuation can feel confusing, so look through the numbers yourself and decide how comfortable you are with the trade off between risk and reward, starting with the 3 key rewards and 3 important warning signs.
CHCT combines a high 10.91% dividend yield with weak interest coverage and earnings that rely partly on a US$1.8 million one off gain.
If that mix of tight coverage and payout pressure feels uncomfortable, compare it with companies that score better on debt and cash strength using the solid balance sheet and fundamentals stocks screener (46 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com